25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

VIVIMED LABS LTD.
Buy, Hold or Sell?

Let's analyze VIVIMED LABS LTD. together

I guess you are interested in VIVIMED LABS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of VIVIMED LABS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about VIVIMED LABS LTD.

I send you an email if I find something interesting about VIVIMED LABS LTD..

1. Quick Overview

1.1. Quick analysis of VIVIMED LABS LTD. (30 sec.)










1.2. What can you expect buying and holding a share of VIVIMED LABS LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
57.1%

What is your share worth?

Current worth
INR4.75
Expected worth in 1 year
INR-151.97
How sure are you?
42.9%

+ What do you gain per year?

Total Gains per Share
INR-156.72
Return On Investment
-3,198.4%

For what price can you sell your share?

Current Price per Share
INR4.90
Expected price per share
INR4.9 - INR4.9
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of VIVIMED LABS LTD. (5 min.)




Live pricePrice per Share (EOD)
INR4.90
Intrinsic Value Per Share
INR76.51 - INR235.71
Total Value Per Share
INR81.26 - INR240.47

2.2. Growth of VIVIMED LABS LTD. (5 min.)




Is VIVIMED LABS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$4.6m$43.3m-$38.6m-824.0%

How much money is VIVIMED LABS LTD. making?

Current yearPrevious yearGrowGrow %
Making money-$39m-$8m-$31m-79.4%
Net Profit Margin-175.6%-28.5%--

How much money comes from the company's main activities?

2.3. Financial Health of VIVIMED LABS LTD. (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of VIVIMED LABS LTD.?

Welcome investor! VIVIMED LABS LTD.'s management wants to use your money to grow the business. In return you get a share of VIVIMED LABS LTD..

First you should know what it really means to hold a share of VIVIMED LABS LTD.. And how you can make/lose money.

Speculation

The Price per Share of VIVIMED LABS LTD. is INR4.9. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of VIVIMED LABS LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in VIVIMED LABS LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR4.75. Based on the TTM, the Book Value Change Per Share is INR-39.18 per quarter. Based on the YOY, the Book Value Change Per Share is INR-8.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of VIVIMED LABS LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.47-9.6%-0.47-9.6%-0.10-2.0%-0.15-3.0%-0.05-1.0%
Usd Book Value Change Per Share-0.47-9.5%-0.47-9.5%-0.10-2.0%-0.34-7.0%0.010.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.091.9%0.071.4%
Usd Total Gains Per Share-0.47-9.5%-0.47-9.5%-0.10-2.0%-0.25-5.2%0.071.5%
Usd Price Per Share0.08-0.08-0.17-0.16-0.42-
Price to Earnings Ratio-0.17--0.17--1.77--0.19-1.54-
Price-to-Total Gains Ratio-0.17--0.17--1.78-1.17-1.17-
Price to Book Ratio1.40-1.40-0.33-0.46-0.57-
Price-to-Total Gains Ratio-0.17--0.17--1.78-1.17-1.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.05831
Number of shares17149
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.09
Usd Book Value Change Per Share-0.47-0.34
Usd Total Gains Per Share-0.47-0.25
Gains per Quarter (17149 shares)-7,995.74-4,334.88
Gains per Year (17149 shares)-31,982.96-17,339.53
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-31983-319936274-23613-17350
20-63966-6397612548-47227-34690
30-95949-9595918822-70840-52030
40-127932-12794225096-94454-69370
50-159915-15992531370-118067-86710
60-191898-19190837644-141681-104050
70-223881-22389143918-165294-121390
80-255864-25587450192-188908-138730
90-287847-28785756465-212521-156070
100-319830-31984062739-236135-173410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.04.00.042.9%3.04.00.042.9%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.05.00.028.6%2.05.00.028.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%2.00.03.040.0%4.00.03.057.1%4.00.03.057.1%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.04.00.042.9%3.04.00.042.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of VIVIMED LABS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---39.181-39.1810%-8.116-79%-28.928-26%0.679-5868%
Book Value Per Share--4.7554.7550%43.935-89%63.045-92%78.847-94%
Current Ratio--0.7830.7830%1.359-42%1.272-38%1.332-41%
Debt To Asset Ratio--0.9600.9600%0.712+35%0.711+35%0.670+43%
Debt To Equity Ratio--24.07024.0700%2.475+872%6.330+280%4.921+389%
Dividend Per Share----0%-0%7.686-100%5.603-100%
Eps---39.623-39.6230%-8.159-79%-12.539-68%-3.927-90%
Free Cash Flow Per Share--3.6613.6610%-79.416+2269%5.765-36%1.488+146%
Free Cash Flow To Equity Per Share--3.6613.6610%-80.668+2303%-25.378+793%-16.954+563%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--235.715--------
Intrinsic Value_10Y_min--76.509--------
Intrinsic Value_1Y_max--9.636--------
Intrinsic Value_1Y_min--0.105--------
Intrinsic Value_3Y_max--39.610--------
Intrinsic Value_3Y_min--6.866--------
Intrinsic Value_5Y_max--82.433--------
Intrinsic Value_5Y_min--20.756--------
Market Cap406278129.600-36%553035813.050553035813.0500%1198106071.750-54%1121493562.810-51%2903526539.150-81%
Net Profit Margin---1.756-1.7560%-0.285-84%-0.438-75%-0.282-84%
Operating Margin----0%-0.1060%-0.0130%0.044-100%
Operating Ratio--3.5963.5960%1.752+105%1.953+84%1.761+104%
Pb Ratio1.031-36%1.4031.4030%0.329+327%0.463+203%0.573+145%
Pe Ratio-0.124+27%-0.168-0.1680%-1.771+952%-0.187+11%1.535-111%
Price Per Share4.900-36%6.6706.6700%14.450-54%13.526-51%35.019-81%
Price To Free Cash Flow Ratio1.338-36%1.8221.8220%-0.182+110%0.129+1315%-12.489+785%
Price To Total Gains Ratio-0.125+27%-0.170-0.1700%-1.781+946%1.166-115%1.169-115%
Quick Ratio--0.3240.3240%0.234+38%0.337-4%0.352-8%
Return On Assets---0.332-0.3320%-0.053-84%-0.094-72%-0.047-86%
Return On Equity---8.334-8.3340%-0.186-98%-1.754-79%-1.200-86%
Total Gains Per Share---39.181-39.1810%-8.116-79%-21.242-46%6.282-724%
Usd Book Value--4691337.0004691337.0000%43350045.900-89%62205355.520-92%77796154.800-94%
Usd Book Value Change Per Share---0.466-0.4660%-0.097-79%-0.344-26%0.008-5868%
Usd Book Value Per Share--0.0570.0570%0.523-89%0.750-92%0.938-94%
Usd Dividend Per Share----0%-0%0.091-100%0.067-100%
Usd Eps---0.472-0.4720%-0.097-79%-0.149-68%-0.047-90%
Usd Free Cash Flow--3612126.0003612126.0000%-78357727.700+2269%5687973.900-36%1468077.500+146%
Usd Free Cash Flow Per Share--0.0440.0440%-0.945+2269%0.069-36%0.018+146%
Usd Free Cash Flow To Equity Per Share--0.0440.0440%-0.960+2303%-0.302+793%-0.202+563%
Usd Market Cap4834709.742-36%6581126.1756581126.1750%14257462.254-54%13345773.397-51%34551965.816-81%
Usd Price Per Share0.058-36%0.0790.0790%0.172-54%0.161-51%0.417-81%
Usd Profit---39095427.000-39095427.0000%-8050373.800-79%-12512331.160-68%-3842700.400-90%
Usd Revenue--22264781.00022264781.0000%28237164.900-21%87300270.680-74%107366043.200-79%
Usd Total Gains Per Share---0.466-0.4660%-0.097-79%-0.253-46%0.075-724%
 EOD+4 -4MRQTTM+0 -0YOY+8 -245Y+3 -3110Y+7 -28

3.3 Fundamental Score

Let's check the fundamental score of VIVIMED LABS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.124
Price to Book Ratio (EOD)Between0-11.031
Net Profit Margin (MRQ)Greater than0-1.756
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.324
Current Ratio (MRQ)Greater than10.783
Debt to Asset Ratio (MRQ)Less than10.960
Debt to Equity Ratio (MRQ)Less than124.070
Return on Equity (MRQ)Greater than0.15-8.334
Return on Assets (MRQ)Greater than0.05-0.332
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of VIVIMED LABS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 504.900
Ma 50Greater thanMa 1004.900
Ma 100Greater thanMa 2004.900
OpenGreater thanClose4.900
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About VIVIMED LABS LTD.

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates in two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also offers active ingredients primarily for hair dye and photochromic applications. Additionally, the company manufactures Favulous tablets for the treatment of mild to moderate cases of Covid-19. Its products are used in home, personal, and industrial care segments. The company also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.

Fundamental data was last updated by Penke on 2024-10-27 14:11:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit VIVIMED LABS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare VIVIMED LABS LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -175.6% means that ₹-1.76 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of VIVIMED LABS LTD.:

  • The MRQ is -175.6%. The company is making a huge loss. -2
  • The TTM is -175.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-175.6%TTM-175.6%0.0%
TTM-175.6%YOY-28.5%-147.1%
TTM-175.6%5Y-43.8%-131.8%
5Y-43.8%10Y-28.2%-15.6%
4.3.1.2. Return on Assets

Shows how efficient VIVIMED LABS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare VIVIMED LABS LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • -33.2% Return on Assets means that VIVIMED LABS LTD. generated ₹-0.33 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of VIVIMED LABS LTD.:

  • The MRQ is -33.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -33.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-33.2%TTM-33.2%0.0%
TTM-33.2%YOY-5.3%-27.9%
TTM-33.2%5Y-9.4%-23.8%
5Y-9.4%10Y-4.7%-4.7%
4.3.1.3. Return on Equity

Shows how efficient VIVIMED LABS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare VIVIMED LABS LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • -833.4% Return on Equity means VIVIMED LABS LTD. generated ₹-8.33 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of VIVIMED LABS LTD.:

  • The MRQ is -833.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -833.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-833.4%TTM-833.4%0.0%
TTM-833.4%YOY-18.6%-814.8%
TTM-833.4%5Y-175.4%-658.0%
5Y-175.4%10Y-120.0%-55.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of VIVIMED LABS LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient VIVIMED LABS LTD. is operating .

  • Measures how much profit VIVIMED LABS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare VIVIMED LABS LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of VIVIMED LABS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-10.6%+10.6%
TTM-5Y-1.3%+1.3%
5Y-1.3%10Y4.4%-5.7%
4.3.2.2. Operating Ratio

Measures how efficient VIVIMED LABS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 3.60 means that the operating costs are ₹3.60 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of VIVIMED LABS LTD.:

  • The MRQ is 3.596. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.596. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.596TTM3.5960.000
TTM3.596YOY1.752+1.843
TTM3.5965Y1.953+1.643
5Y1.95310Y1.761+0.191
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of VIVIMED LABS LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if VIVIMED LABS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.78 means the company has ₹0.78 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of VIVIMED LABS LTD.:

  • The MRQ is 0.783. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.783. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.783TTM0.7830.000
TTM0.783YOY1.359-0.575
TTM0.7835Y1.272-0.489
5Y1.27210Y1.332-0.060
4.4.3.2. Quick Ratio

Measures if VIVIMED LABS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare VIVIMED LABS LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.32 means the company can pay off ₹0.32 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of VIVIMED LABS LTD.:

  • The MRQ is 0.324. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.324. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.324TTM0.3240.000
TTM0.324YOY0.234+0.090
TTM0.3245Y0.337-0.013
5Y0.33710Y0.352-0.015
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of VIVIMED LABS LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of VIVIMED LABS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare VIVIMED LABS LTD. to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.96 means that VIVIMED LABS LTD. assets are financed with 96.0% credit (debt) and the remaining percentage (100% - 96.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of VIVIMED LABS LTD.:

  • The MRQ is 0.960. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.960. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.960TTM0.9600.000
TTM0.960YOY0.712+0.248
TTM0.9605Y0.711+0.249
5Y0.71110Y0.670+0.041
4.5.4.2. Debt to Equity Ratio

Measures if VIVIMED LABS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare VIVIMED LABS LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 2,407.0% means that company has ₹24.07 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of VIVIMED LABS LTD.:

  • The MRQ is 24.070. The company is unable to pay all its debts with equity. -1
  • The TTM is 24.070. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ24.070TTM24.0700.000
TTM24.070YOY2.475+21.595
TTM24.0705Y6.330+17.741
5Y6.33010Y4.921+1.409
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings VIVIMED LABS LTD. generates.

  • Above 15 is considered overpriced but always compare VIVIMED LABS LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -0.17 means the investor is paying ₹-0.17 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of VIVIMED LABS LTD.:

  • The EOD is -0.124. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.168. Based on the earnings, the company is expensive. -2
  • The TTM is -0.168. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.124MRQ-0.168+0.045
MRQ-0.168TTM-0.1680.000
TTM-0.168YOY-1.771+1.603
TTM-0.1685Y-0.187+0.019
5Y-0.18710Y1.535-1.723
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of VIVIMED LABS LTD.:

  • The EOD is 1.338. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.822. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1.822. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.338MRQ1.822-0.483
MRQ1.822TTM1.8220.000
TTM1.822YOY-0.182+2.004
TTM1.8225Y0.129+1.693
5Y0.12910Y-12.489+12.618
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of VIVIMED LABS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.40 means the investor is paying ₹1.40 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of VIVIMED LABS LTD.:

  • The EOD is 1.031. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.403. Based on the equity, the company is underpriced. +1
  • The TTM is 1.403. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.031MRQ1.403-0.372
MRQ1.403TTM1.4030.000
TTM1.403YOY0.329+1.074
TTM1.4035Y0.463+0.940
5Y0.46310Y0.573-0.110
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-03-312020-03-312021-03-312022-03-312023-03-31
Retained Earnings  3,496,080-1,114,2702,381,810-725,1801,656,630-678,490978,140-3,436,980-2,458,840
Net Working Capital  3,416,740-1,367,5402,049,200-176,5121,872,688-537,5911,335,097-2,255,247-920,150
Gross Profit  6,630,190-1,774,2004,855,990213,4295,069,419-4,231,375838,044-1,766,694-928,650



6.2. Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets9,883,440
Total Liabilities9,489,210
Total Stockholder Equity394,230
 As reported
Total Liabilities 9,489,210
Total Stockholder Equity+ 394,230
Total Assets = 9,883,440

Assets

Total Assets9,883,440
Total Current Assets3,322,850
Long-term Assets6,560,590
Total Current Assets
Cash And Cash Equivalents 37,620
Short-term Investments 606,160
Net Receivables 768,110
Inventory 797,600
Other Current Assets 1,321,530
Total Current Assets  (as reported)3,322,850
Total Current Assets  (calculated)3,531,020
+/- 208,170
Long-term Assets
Property Plant Equipment 2,988,400
Goodwill 169,140
Intangible Assets 1,407,260
Long-term Assets Other 7,580
Long-term Assets  (as reported)6,560,590
Long-term Assets  (calculated)4,572,380
+/- 1,988,210

Liabilities & Shareholders' Equity

Total Current Liabilities4,243,000
Long-term Liabilities5,246,210
Total Stockholder Equity394,230
Total Current Liabilities
Short Long Term Debt 3,162,470
Accounts payable 694,130
Other Current Liabilities 182,910
Total Current Liabilities  (as reported)4,243,000
Total Current Liabilities  (calculated)4,039,510
+/- 203,490
Long-term Liabilities
Long term Debt 623,190
Capital Lease Obligations Min Short Term Debt24,690
Long-term Liabilities Other 60,300
Long-term Liabilities  (as reported)5,246,210
Long-term Liabilities  (calculated)708,180
+/- 4,538,030
Total Stockholder Equity
Total Stockholder Equity (as reported)394,230
Total Stockholder Equity (calculated)0
+/- 394,230
Other
Capital Stock165,830
Common Stock Shares Outstanding 82,914
Net Debt 3,748,040
Net Invested Capital 4,179,890
Net Working Capital -920,150
Property Plant and Equipment Gross 2,988,400



6.3. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
20,655,220
23,936,280
23,291,670
22,096,190
12,893,298
12,660,155
9,883,440
9,883,44012,660,15512,893,29822,096,19023,291,67023,936,28020,655,220
   > Total Current Assets 
10,944,170
12,819,410
12,306,100
9,890,050
5,287,100
5,072,670
3,322,850
3,322,8505,072,6705,287,1009,890,05012,306,10012,819,41010,944,170
       Cash And Cash Equivalents 
554,730
990,330
945,040
504,890
64,313
71,839
37,620
37,62071,83964,313504,890945,040990,330554,730
       Short-term Investments 
0
0
0
0
0
0
606,160
606,160000000
       Net Receivables 
2,624,770
3,607,690
4,347,790
2,490,670
1,075,031
873,640
768,110
768,110873,6401,075,0312,490,6704,347,7903,607,6902,624,770
       Inventory 
4,839,680
5,401,660
5,636,860
5,019,080
2,556,830
2,407,660
797,600
797,6002,407,6602,556,8305,019,0805,636,8605,401,6604,839,680
       Other Current Assets 
2,700,630
2,530,110
1,098,700
616,780
1,207,160
1,131,370
1,321,530
1,321,5301,131,3701,207,160616,7801,098,7002,530,1102,700,630
   > Long-term Assets 
9,582,840
11,116,870
10,985,580
12,343,410
7,606,204
7,587,483
6,560,590
6,560,5907,587,4837,606,20412,343,41010,985,58011,116,8709,582,840
       Property Plant Equipment 
7,284,970
8,099,870
7,843,400
7,874,730
4,082,553
4,025,977
2,988,400
2,988,4004,025,9774,082,5537,874,7307,843,4008,099,8707,284,970
       Goodwill 
0
2,176,260
2,176,250
2,176,250
0
169,140
169,140
169,140169,14002,176,2502,176,2502,176,2600
       Intangible Assets 
0
730,150
852,640
1,293,010
0
1,404,160
1,407,260
1,407,2601,404,16001,293,010852,640730,1500
       Other Assets 
97,720
83,600
88,180
5,030
30
10
0
010305,03088,18083,60097,720
> Total Liabilities 
13,416,260
11,549,500
13,853,730
13,750,280
8,577,535
9,017,294
9,489,210
9,489,2109,017,2948,577,53513,750,28013,853,73011,549,50013,416,260
   > Total Current Liabilities 
8,173,900
7,902,310
8,889,350
7,699,910
3,410,750
3,733,910
4,243,000
4,243,0003,733,9103,410,7507,699,9108,889,3507,902,3108,173,900
       Short Long Term Debt 
5,626,570
4,987,980
5,299,100
4,722,990
1,952,471
2,177,032
3,162,470
3,162,4702,177,0321,952,4714,722,9905,299,1004,987,9805,626,570
       Accounts payable 
1,785,930
2,019,940
2,944,240
2,265,010
342,520
418,940
694,130
694,130418,940342,5202,265,0102,944,2402,019,9401,785,930
       Other Current Liabilities 
769,920
548,800
351,010
202,250
187,380
185,680
182,910
182,910185,680187,380202,250351,010548,800769,920
   > Long-term Liabilities 
5,257,670
3,647,190
4,964,380
6,046,700
5,163,129
5,279,719
5,246,210
5,246,2105,279,7195,163,1296,046,7004,964,3803,647,1905,257,670
       Long term Debt 
4,526,960
3,251,970
4,248,010
4,703,940
574,266
606,272
623,190
623,190606,272574,2664,703,9404,248,0103,251,9704,526,960
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
24,690
24,690000000
       Other Liabilities 
570,130
395,220
716,370
1,342,760
4,588,860
4,673,450
0
04,673,4504,588,8601,342,760716,370395,220570,130
       Long-term Liabilities Other 
598,080
91,340
315,710
356,340
50,028
60,316
60,300
60,30060,31650,028356,340315,71091,340598,080
> Total Stockholder Equity
7,238,960
12,263,970
9,437,940
8,345,910
4,315,763
3,642,861
394,230
394,2303,642,8614,315,7638,345,9109,437,94012,263,9707,238,960
   Common Stock
162,040
165,050
165,050
165,830
165,830
165,830
0
0165,830165,830165,830165,050165,050162,040
   Retained Earnings 
5,474,800
6,218,000
3,496,080
2,381,810
1,656,630
978,140
-2,458,840
-2,458,840978,1401,656,6302,381,8103,496,0806,218,0005,474,800
   Accumulated Other Comprehensive Income 0000000
   Capital Surplus 0000000
   Treasury Stock0000000



6.4. Balance Sheets

Currency in INR. All numbers in thousands.




6.5. Cash Flows

Currency in INR. All numbers in thousands.




6.6. Income Statements

Currency in INR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,870,990
Cost of Revenue-2,799,640
Gross Profit-928,650-928,650
 
Operating Income (+$)
Gross Profit-928,650
Operating Expense-3,927,930
Operating Income-2,056,940-4,856,580
 
Operating Expense (+$)
Research Development2,660
Selling General Administrative208,930
Selling And Marketing Expenses0
Operating Expense3,927,930211,590
 
Net Interest Income (+$)
Interest Income0
Interest Expense-350,040
Other Finance Cost-12,230
Net Interest Income-362,270
 
Pretax Income (+$)
Operating Income-2,056,940
Net Interest Income-362,270
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,306,500-2,056,940
EBIT - interestExpense = -350,040
-3,285,330
-2,935,290
Interest Expense350,040
Earnings Before Interest and Taxes (EBIT)0-2,956,460
Earnings Before Interest and Taxes (EBITDA)-1,863,410
 
After tax Income (+$)
Income Before Tax-3,306,500
Tax Provision--21,170
Net Income From Continuing Ops-3,285,330-3,285,330
Net Income-3,285,330
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0362,270
 

Technical Analysis of VIVIMED LABS LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of VIVIMED LABS LTD.. The general trend of VIVIMED LABS LTD. is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine VIVIMED LABS LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of VIVIMED LABS LTD..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.9 < 4.9 < 4.9.

The bearish price targets are: 4.9 > 4.9 > 4.9.

Tweet this
VIVIMED LABS LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of VIVIMED LABS LTD.. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

VIVIMED LABS LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of VIVIMED LABS LTD.. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the VIVIMED LABS LTD. price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for VIVIMED LABS LTD.. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the VIVIMED LABS LTD. price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
VIVIMED LABS LTD. Daily Moving Average Convergence/Divergence (MACD) ChartVIVIMED LABS LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of VIVIMED LABS LTD.. The current adx is 82.14.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
VIVIMED LABS LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of VIVIMED LABS LTD.. The current sar is 4.89979467.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
VIVIMED LABS LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of VIVIMED LABS LTD.. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
VIVIMED LABS LTD. Daily Relative Strength Index (RSI) ChartVIVIMED LABS LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of VIVIMED LABS LTD.. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the VIVIMED LABS LTD. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
VIVIMED LABS LTD. Daily Stochastic Oscillator ChartVIVIMED LABS LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of VIVIMED LABS LTD.. The current cci is -66.66666667.

VIVIMED LABS LTD. Daily Commodity Channel Index (CCI) ChartVIVIMED LABS LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of VIVIMED LABS LTD.. The current cmo is 0.

VIVIMED LABS LTD. Daily Chande Momentum Oscillator (CMO) ChartVIVIMED LABS LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of VIVIMED LABS LTD.. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
VIVIMED LABS LTD. Daily Williams %R ChartVIVIMED LABS LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of VIVIMED LABS LTD..

VIVIMED LABS LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of VIVIMED LABS LTD.. The current atr is 0.

VIVIMED LABS LTD. Daily Average True Range (ATR) ChartVIVIMED LABS LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of VIVIMED LABS LTD.. The current obv is 686,109.

VIVIMED LABS LTD. Daily On-Balance Volume (OBV) ChartVIVIMED LABS LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of VIVIMED LABS LTD.. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
VIVIMED LABS LTD. Daily Money Flow Index (MFI) ChartVIVIMED LABS LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for VIVIMED LABS LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

VIVIMED LABS LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of VIVIMED LABS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 504.900
Ma 50Greater thanMa 1004.900
Ma 100Greater thanMa 2004.900
OpenGreater thanClose4.900
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of VIVIMED LABS LTD. with someone you think should read this too:
  • Are you bullish or bearish on VIVIMED LABS LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about VIVIMED LABS LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about VIVIMED LABS LTD.

I send you an email if I find something interesting about VIVIMED LABS LTD..


Comments

How you think about this?

Leave a comment

Stay informed about VIVIMED LABS LTD..

Receive notifications about VIVIMED LABS LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.